Recovery (SFS-RR) is a technique that uses supplementary structural information from MR or CT to improve the spatial resolution of PET or SPECT images. This wavelet-based method may have a potential impact on the clinical decision-making of brain focal disorders such as refractory epilepsy, since it can produce images with better quantitative accuracy and enhanced detectability. In this work, a method for the iterative application of SFS-RR (iSFS-RR) was firstly developed and optimized in terms of convergence and input voxel size, and the corrected images were used for the diagnosis of 18 patients with refractory epilepsy. To this end, PET/MR images were clinically evaluated through visual inspection, atlas-based asymmetry indices (AIs) and SPM (Statistical Parametric Mapping) analysis, using uncorrected images and images corrected with SFS-RR and iSFS-RR. Our results showed that the sensitivity can be increased from 78% for uncorrected images, to 84% for SFS-RR and 94% for the proposed iSFS-RR. Thus, the proposed methodology has demonstrated the potential to improve the management of refractory epilepsy patients in the clinical routine.
Iterative Structural and Functional Synergistic Resolution Recovery (iSFS-RR) Applied to PET-MR
Images in Epilepsy I. INTRODUCTION P OSITRON emission tomography (PET) is a non-invasive imaging technique that visualizes the distribution of different radiotracers in the body, providing functional and molecular information on tissue. PET is widely used in neurology for in vivo examination of brain function, allowing the quantification of cerebral blood flow, glucose metabolism, receptor binding and many other physiological parameters [1] . PET has been proven a valuable tool on the evaluation of Parkinson's disease, Huntington's disease, multiple sclerosis, dementias and epilepsy [2] . In the latter case, PET and subtraction ictal single photon emission computed tomography (SPECT) co-registered to magnetic resonance imaging (MRI), known also as SISCOM, are routinely used as complements for MRI in the localization of the epileptogenic focus before surgery [3] , [4] . For this particular application, PET has a leading role since it has demonstrated to be simpler than SISCOM and more sensitive than MRI in certain situations [5] , [6] . Furthermore, the usefulness and sensitivity of PET have been increased in the later years by two main facts. First, the availability of co-registered PET/MR images has improved the interpretation of images of both modalities and enabled a more straightforward use of PET information on MRI-guided surgery [7] . Second, the use of PET quantification techniques, such as Atlas-based Asymmetry Indices (AI) and Statistical Parametric Mapping (SPM) on the clinic has improved the localization of the epileptogenic focus [8] , [9] . Despite these advancements, the sensitivity of PET in epilepsy is still relatively low [5] , [6] , [9] , [10] , especially when dealing with small focal hypometabolisms, due to the limited resolution of PET images. This limitation is of crucial importance since the size of the hypometabolism is inversely correlated with the surgery outcome [11] . In this context, techniques that can provide an improvement on PET resolution have a great potential to improve the localization of these small hypometabolisms and consequently the surgery outcome.
Several approaches have been suggested for the use of supplementary MRI-based structural information for the resolution recovery (RR) of PET images [12] , [13] . These techniques provide some advantages compared to conventional RR approaches modeling the point-spread function (PSF) into the reconstruction, especially due to better noise handling [14] , [15] . Furthermore, several iterative reconstruction algorithms integrate anatomical information in order to control noise without resolution degradation [16] , [17] . Recently, the use of an 0018-9499 © 2016 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission.
See http://www.ieee.org/publications_standards/publications/rights/index.html for more information. anatomical brain atlas was introduced as a source of structural information for the improvement of PET resolution [12] , [18] , [19] . The use of high-frequency structural information enhances the resolution of the PET images without significantly altering its functional patterns. One of the most promising techniques using this approach is the Structural Functional Synergistic Resolution Recovery (SFS-RR) [18] , which has provided excellent results on simulations, phantoms, and in some particular clinical cases with both neurology and oncology patients [20] - [23] . This methodology may have potential impact on clinical decision-making in epilepsy since it can produce images with enhanced contrast and improved lesion detectability when visually inspecting PET data. Nevertheless, the method has some shortcomings: First, in SFS-RR an atlas with white and grey matter information obtained from the MRI (usually a T1 image) is filled with quantitative values obtained from the PET image. These values are affected by Partial Volume Effect (PVE), which will limit the accuracy of the correction. Second, wavelet decomposition is a very time consuming process due to the large number of pixels in clinical MR images. The use of larger voxels can remarkably reduce this time demand but it could have an impact on the segmentation accuracy. These limitations should be assessed before the widespread use of this methodology in clinical routine.
In this work, we aim at developing, optimizing and evaluating a novel methodology for the iterative application of SFS-RR (iSFS-RR). We evaluate the potential of the developed methodology to provide an improved localization of small focal hypometabolisms and consequently an improvement in the diagnosis of focal disorders such as epilepsy. For this, a group of patients previously diagnosed with refractory epilepsy was re-evaluated using images corrected with the novel methodology.
II. METHODS

A. SFS-RR
The wavelet transform (WT) provides a framework to decompose images into a number of new images, each one of them with a different degree of resolution [24] . The basic idea of RR using wavelets is to decompose the functional (PET or SPECT) and the structural reference image (MRI, CT or other) into several resolution elements using the wavelet transform (WT) and then replace the high-resolution components of the functional image with the ones of the anatomical image with appropriate scaling. In this way the details of the highresolution image are extracted, transformed and integrated into the low-resolution image [25] . The main limitation of waveletbased RR is that functional and anatomical distributions may differ leading to artifacts or alterations of the functional patterns on the final functional images. To prevent this, the replacement of functional with structural information is performed locally by evaluating the ratio between functional and structural signal in the wavelet domain. However, this may not be sufficient as no single structural image may provide the anatomical support for the functional study at hand. An alternative solution is to use an anatomical frequency-based brain atlas as a source of structural information for the RR process [18] . Fig. 1 (red box) shows the steps of the SFS-RR correction proposed by Shidahara et al. [18] :
a. T1-MRI is segmented into white and grey matter and this information combined with the Hammersmith atlas to generate a probabilistic anatomy-based atlas with Regions of Interest (ROIs) for grey and white matter. b. Each Region of Interest (ROI) of the generated anatomybased atlas is filled with the average uptake in the patient's PET scan for each ROI, generating a segmented atlas with anatomical and functional information.
c. The PET image and the corresponding segmented atlas are decomposed into several resolutions using the dualtree complex wavelet transform (CWT) [26] , which decomposes the image into multiple directional features (six quadrants with directionalities ±15
• , ±45
• and ±75
• ). d. The high frequencies from the segmented atlas are weighted using three levels of scaling and introduced into the PET data. The high-resolution wavelet coefficients of the corrected image are calculated as:
corr are the segmented atlas, PET and corrected PET wavelet coefficients, β is a coefficient accounting for the difference in resolutions between the two images, γ is the branching factor that weights anatomical versus functional information and α is a global calibration factor compensating for the different intensity between anatomical and PET wavelet coefficients. e. Finally, the PET image is recomposed resolutionrecovered.
B. iSFS-RR
The accuracy of SFS-RR when applied to clinical data is limited by PVE, which significantly bias the generation of the PET-based segmented atlas, an essential step of the correction. In this work, we propose an iterative method for the application of the SFS-RR (iSFS-RR), which could increase the accuracy in the generation of the segmented atlas. Since the output of the SFS-RR is corrected for PVE, it can be used to re-generate the segmented atlas and perform the correction again, obtaining a more accurate result. The wavelet coefficients of the corrected image for iteration n are calculated as:
where β n , γ n and α n are the aforementioned coefficients for each iteration. This process can be repeated until the output PET has converged. Fig. 1 (orange box) illustrates the proposed iterative loop. The first iteration of this process is equivalent to the conventional SFS-RR.
C. Patients
In this work we retrospectively re-evaluated images from 18 patients with intractable temporal lobe epilepsy (TLE). These patients have been previously diagnosed and operated on the patients by the Refractory Epilepsy Surgery Unit at the University Hospital of Santiago de Compostela in the period 2012-2013. Following the Refractory Epilepsy Surgery Unit protocol, all of them underwent FDG-PET, 3T-MRI, video electro-encephalography and a wide range of neurological and neuropsychological tests. The epilepsy diagnosis and focus localization was obtained evaluating the results coming from the whole group of tests. We also used images from 97 control subjects. These images were obtained from pre-treatment oncologic patients that underwent FDG-PET after signed consent. All of the control subjects were examined for ensuring that there are no signs of a neurologic or psychiatric disease and the obtained images were evaluated by two experienced nuclear medicine physicians and were considered normal. All the images were acquired following the protocols detailed below.
D. Imaging Protocols a) FDG-PET:
all patients underwent the routine neuroimaging protocol at our institution. Starting 45 min after intravenous injection of 370 MBq of 18 F − FDG, the patients were scanned for 30 min for emission data and 15 min for transmission data, required for attenuation correction. The imaging device was a GE Advance NXi PET scanner (General Electrics Healthcare, Little Chalfont, Buckinghamshire, United Kingdom). Following the default protocols of the GE Advance, scatter, randoms, attenuation and normalization corrections were applied before the reconstruction. PSF modeling and motion correction were not included. The images were reconstructed using 3D ordered subsets expectation maximization (3D-OSEM), with 4 subsets and 16 iterations. The size of the reconstructed image is 128 × 128 × 35, with a voxel size of 2 × 2 × 4.25 mm 3 . No smoothing was applied during or to the images during the reconstruction.
b) 3T-MRI: structural imaging was performed with an Achieva 3.0T X-series MR imaging scanner (Philips Healthcare, Best, The Netherlands) using a head coil. The MRI protocol consisted of the acquisition of T1-weighted 3D TFE, FLAIR and T2-weighted sequences. The different sequences were visually evaluated for diagnosis following the protocols of the Refractory Epilepsy Surgery Unit. Additionally, the T1-weighted 3D TFE was used as an input for the PVE correction.
E. Image Analysis
PET and T1-MRI sequences were co-registered and analyzed using statistical parametric mapping (SPM) software package (SPM12, Wellcome Trust Centre for Neuroimaging, University College London, United Kingdom). Two experienced physicians visually inspected PET/MR co-registered images assisted by the report from the EEG and neurological tests, as in a conventional clinical evaluation. For a more objective analysis, calculations of asymmetry indices (AI) and a voxel-by-voxel statistical comparison were performed. Fig. 2 shows an example of the results of the performed analysis.
a) PET/MR Co-Registering: The co-registering of T1-MRI and PET images was performed with the SPM package. The used algorithm is similar to the one presented by Collignon et al. [27] . The original interpolation method described in this paper has been changed in order to give a smoother cost function in order to make the cost function as smooth as possible, to give faster convergence and less chance of local minima. The co-registered PET has the same matrix and pixel size of the MR image. 
b) Asymmetry Indices (AI):
The asymmetry calculations were based on the ROIs of the Hammersmith atlas [28] , specifically designed for TLE. The group of 97 control subjects was used for generating a template of the average uptake of the healthy brain on the Montreal Neurological Institute (MNI). The original T1-MRI images were normalized to the MNI space using SPM. Spatial normalization is done via a segmentation routine [29] . The transformation matrix is inverted and applied to the atlas and the healthy brain template, taking them to the patient space. The PET image (co-registered to the T1-MRI) is proportionally scaled to the healthy brain template to eliminate global differences. Differences on the average uptake between the patient PET (VM p ) and the healthy template (VM c ) are calculated for each ROI of the Atlas. Contralateral ROIs are compared to obtain asymmetry indices as:
where L and R stand for left and right sides of the brain, respectively. AIs higher than 5% were considered significant based on the intrinsic AI variability obtained over the control database.
c) Voxel-by-voxel Analysis:
The calculated normalization matrix is applied to the PET image to take it to the MNI space. Afterwards, the patient is compared to the group of 97 healthy patients using a two-sample t-test [30] . All images, including the patient PET image, were smoothed using a 4-mm Gaussian filter. Proportional scaling was used to remove the global differences between subjects. Clusters of 100 pixels with T-scores higher than 3.5 were considered significant.
A positive PET report was emitted when the hypometabolism was observed in the visual inspection (VI) of the PET/MR image and it was reported as positive by one of the performed quantitative analyses (P ET report = V I × (AI + SP M ), where P ET report , VI, AI or SPM equals to 1 for a positive result). Following the aforementioned evaluation protocol, all patients were evaluated by using original PET images and PET images corrected with SFS-RR and with the proposed iSFS-RR method.
F. iSFS-RR Convergence Evaluation
The convergence was evaluated for a sample of 10 patients with previously identified small (5) and extended (5) hypometabolisms using subtraction images of corrected PET images of consecutive iterations. To evaluate this global convergence, we measured two parameters, named maximum change (MC) and average change (AC) and defined as:
where it(n) and it(n − 1) correspond to the actual and previous iteration of the corrected PET images (images are subtracted voxel-by-voxel). Furthermore, we also evaluated the variations along the iterations of the obtained final quantification values (AIs and SPM T-scores). For investigating the impact of different input MRI image sizes on the correction outcome, we corrected the images using input from two different voxel sizes: 256 × 256 × 175 pixels of 1 × 1 × 1 mm 3 and 128 × 128 × 87 pixels of 2 × 2 × 2 mm 3 . The whole process including the segmentation and alignment of the MR and the Hammersmith atlas for the generation of the probabilistic anatomy-based atlas was performed for the two subsets. The latter is especially significant for the high time demand proposed methodology since wavelet decomposition is iteratively performed.
G. Clinical Evaluation
After the convergence evaluation, we fixed a number of iterations for applying the iterative method. The optimized protocol was applied to our database of 18 epilepsy patients. A complete patient report was obtained for images corrected with SFS-RR and with the proposed iSFS-RR. The clinical evaluation was performed with images of 256 × 256 × 175 pixels of 1 × 1 × 1 mm 3 since they were found more convenient for the visual inspection. The results were compared with those of the original PET in order to evaluate the improvements due to the application of SFS-RR and iSFS-RR. Fig. 3 shows the obtained PET images along the iterations for a particular patient. At the bottom of the figure we show the difference images between consecutive iterations for each of the images above. It can be observed in both cases that the method produces images that have visually converged as intended. Fig. 4 shows MC and AC values obtained from iteration 1 to 12 for this patient. Convergence was similar for the whole group, ranging from 4-6 iterations for ensuring MC changes below 5% and AC changes below 2%. Six iterations were finally chosen for the subsequent analysis of iSFS-RR as a reasonable compromise between accuracy and computing time. Table I shows the relative increase of AI and SPM T-score values after 6 iterations for 128 and 256 voxel sizes. The averaged AIs increases were of 3.91% (128 pixels) and 0.11% (256 pixels) for the extended hypometabolisms, and 2.38% (128 pixels) and 2.81% (256 pixels) for the focal hypometabolisms. The averaged T-scores increases were of 2.39% (128 pixels) and 5.21% (256 pixels) for the extended hypometabolisms and 26.10% (128 pixels) and 23.75% (256 pixels) for the focal hypometabolisms. Fig. 5 shows T-score values along the iterations for patients with extended and focal hypometabolisms (iteration 1 is equivalent to the conventional SFS-RR). It can be observed that T-score values converge at iteration 6 for both focal and extended hypometabolisms. It can be observed that both 128 and 256 pixel image sizes converged similarly based on this particular analysis. Fig. 6 shows a visual comparison between original, 128 and 256 pixels corrected images (iSFS-RR, 6 iterations) for Table II shows the full PET reports obtained with uncorrected images, SFS-RR and iSFS-RR.
III. RESULTS
A. Optimization of the iSFS-RR
B. Clinical Evaluation
IV. DISCUSSION
The application of PET in neurological diseases related with small focal hypometabolic areas has been usually hindered by the limited resolution. Improving the resolution of the reconstructed PET images can be performed using two main approaches: image reconstruction with PSF modeling, which can include the use of anatomical priors to guide the regularization, or by applying post-reconstruction PVE correction methods [14] . In Shidahara et al. (2009) [18] , it was shown that improved performance of these wavelet-based methods could be achieved by using a segmented atlas image instead of the raw CT or MR data. An important limitation of this approach is that the PET is used to construct the segmented atlas, and this information, affected by PVE, can limit the effectiveness of the RR technique. This work aimed at the evaluation of an iterative application of the SFS-RR that can potentially solve this issue. The proposed methodology has points in common with the iterative Yang proposed by Erlandsson et al. [14] , where instead of using the WT the authors propose an iterative correction based on the region-based voxel-wise correction (RVB). The methodology for updating the source image is similar to the 'iterative partial volume effect correction' (itPVEC) recently proposed by Shcherbinin and Celler [32] . An assessment of the proposed methodology was firstly carried out in terms of convergence and voxel sizes. The study of convergence showed that iSFS-RR converges after 6 iterations, providing differences between consecutive images below 5% (maximum) and 2% (average). The performance of the proposed methodology in terms of voxel size showed that AIs and T-score values were increased with respect to uncorrected images similarly for 128 and 256 voxels, after 6 iterations. In particular, the latter study showed that T-score values were significantly increased for the focal hypometabolisms, both for 128 and 256 voxels, thus showing that the good quantitative performance of the proposed iSFS-RR. We concluded that the convergence of the method and improvement of the quantitative analysis was similar regardless of the input voxel size, while the processing time can be reduced by a factor three.
After validation and optimization of the methodology, the technique was applied to a group of 18 patients previously diagnosed with refractory epilepsy. Comparisons in terms of sensitivity between uncorrected images, SFS-RR and iSFS-RR images were carried out. Regarding the visual inspection, sensitivity was improved from 78% to 83% and 94% with SFS-RR and iSFS-RR respectively. It has to be mentioned that the physicians also gave overall a more complete description of the lesions for iSFS-RR and SFS-RR, especially when the hippocampus was involved. Regarding the quantitative evaluation, the sensitivity of SPM scores was increased from 50% for uncorrected images to 66% for SFS-RR images and 83% for iSFS-RR images. This is due to that corrected images have better contrast and therefore T-scores values are increased so that more significant differences between the patient and the control group can be reported. The sensitivity of AIs evaluation was 88% regardless of used image, thus showing that the spatial resolution improvement derived from SFS-RR and iSFS-RR corrections does not affect AIs values. This can be explained by the size of the involved ROIs, where the exchanges of counts will happen mainly between white and grey matter within the ROI. Regarding the final report, the sensitivity of the combined evaluation was increased from 78% to 83% for SFS-RR and 94% for iSFS-RR. Although this was mainly derived from the better localization on the visual inspection, it is valuable to mention that iSFS-RR improved the SPM sensitivity, leading to better sensitivities both on visual and SPM evaluations. This is a valuable result for increasing the contribution of quantification to the diagnostic procedure.
V. CONCLUSIONS
A method for the improvement of brain PET spatial resolution based on MRI information was developed and clinically evaluated in patients with epilepsy. Our findings showed that iSFS-RR provided an improved localization of small focal hypometabolisms and consequently an increase in the sensitivity of the diagnosis from 78% to 94%. Furthermore, iSFS-RR improved the sensitivity of the SPM analysis, which is essential for its future integration in clinical routine.
